Microtissues®

Summary

Published in Sensors (2016), this peer-reviewed study used 3D Petri Dish® micro-molds to form scaffold-free 3D microtissues. Full citation: Chennell, George, et al. Imaging of Metabolic Status in 3D Cultures with an Improved AMPK FRET Biosensor for FLIM

🧪 Tissue Engineering & Methods

Imaging of Metabolic Status in 3D Cultures with an Improved AMPK FRET Biosensor for FLIM

Sensors 2016 Chennell, George, et al
Cite as: Chennell, George, et al. Imaging of Metabolic Status in 3D Cultures with an Improved AMPK FRET Biosensor for FLIM. Sensors (2016). doi:10.3390/s16081312 doi.org/10.3390/s16081312

Research Overview

This study developed a way to map biochemical and physiological change inside 3D cultures non-invasively, using FRET biosensors expressed in tumor spheroids and read out by fluorescence lifetime imaging (FLIM).

The centerpiece is an improved AMP-activated protein kinase biosensor, T2AMPKAR, in which replacing the original ECFP donor with mTurquoise2 increased the dynamic range of the response to AMPK activation — demonstrated in 2D with the direct activator 991, then applied to 3D FLIM imaging of tumor spheroids to track metabolic status spatially and over time.

Key Discoveries

  • Improved AMPK FRET biosensor (T2AMPKAR) increased dynamic range by swapping ECFP for mTurquoise2
  • FLIM readouts enabled non-invasive metabolic mapping inside tumor spheroids
  • Validated in 2D with the direct AMPK activator 991, then extended to 3D